Franklin Resources Inc Rocket Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,873,689 shares of RCKT stock, worth $32.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,873,689

Previous 1,867,329 0.34%

Holding current value

$32.3 Million

Previous $50.3 Million 19.81%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $131,397 - $169,939	6,360 Added 0.34%	1,873,689 $40.3 Million
Q1 2024 May 13, 2024	BUY	$26.16 - $30.74 $20.8 Million - $24.4 Million	794,419 Added 74.04%	1,867,329 $50.3 Million
Q4 2023 Feb 09, 2024	BUY	$16.78 - $31.94 $6.81 Million - $13 Million	405,855 Added 60.84%	1,072,910 $32.2 Million
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $9,222 - $14,718	-612 Reduced 0.09%	667,055 $13.7 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $102,061 - $145,187	6,152 Added 0.93%	667,667 $13.3 Million
Q4 2022 Feb 10, 2023	SELL	$15.5 - $22.76 $3,813 - $5,598	-246 Reduced 0.04%	661,515 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $531 - $791	43 Added 0.01%	661,761 $10.6 Million
Q2 2022 Aug 11, 2022	SELL	$7.96 - $16.64 $5.45 Million - $11.4 Million	-684,650 Reduced 50.85%	661,718 $9.11 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $16,436 - $29,576	-1,249 Reduced 0.09%	1,346,368 $21.4 Million
Q4 2021 Feb 11, 2022	SELL	$21.52 - $36.02 $473 - $792	-22 Reduced -0.0%	1,347,617 $29.4 Million
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $2.64 Million - $4.71 Million	-96,200 Reduced 6.66%	1,347,639 $40.3 Million
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $3.55 Million - $4.25 Million	-90,040 Reduced 5.87%	1,443,839 $63.9 Million
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $3.64 Million - $5.53 Million	83,942 Added 5.79%	1,533,879 $68.1 Million
Q4 2020 Feb 10, 2021	BUY	$23.3 - $59.57 $8.87 Million - $22.7 Million	380,545 Added 35.59%	1,449,937 $79.5 Million
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $3.9 Million - $5.43 Million	190,041 Added 21.61%	1,069,392 $24.4 Million
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $6.86 Million - $11.6 Million	515,251 Added 141.51%	879,351 $22.3 Million
Q1 2020 May 13, 2020	SELL	$9.71 - $25.11 $701,780 - $1.81 Million	-72,274 Reduced 16.56%	364,100 $5.08 Million
Q4 2019 Feb 12, 2020	SELL	$11.07 - $24.23 $264,573 - $579,097	-23,900 Reduced 5.19%	436,374 $9.93 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $3.43 Million - $4.53 Million	228,571 Added 98.65%	460,274 $6.9 Million
Q2 2018 Aug 14, 2018	BUY	$14.58 - $23.0 $3.38 Million - $5.33 Million	231,703 New	231,703 $4.55 Million

Others Institutions Holding RCKT

# of Institutions

193

Shares Held

92.4M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.31B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Rocket Pharmaceuticals, Inc. Transaction History